Investigational Site Number : 6430004

Smolensk 214018

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Type 1 Diabetes Mellitus

Studies at this site

• Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus — Completed